Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6.
Publication
, Journal Article
Ardolino, LC; Dear, R; Armstrong, AJ; Gillessen, S; Joshua, AM
Published in: Eur Urol
October 2023
Duke Scholars
Published In
Eur Urol
DOI
EISSN
1873-7560
Publication Date
October 2023
Volume
84
Issue
4
Start / End Page
e94 / e95
Location
Switzerland
Related Subject Headings
- Urology & Nephrology
- Treatment Outcome
- Radiopharmaceuticals
- Radioisotopes
- Prostatic Neoplasms, Castration-Resistant
- Prostate-Specific Antigen
- Male
- Lutetium
- Humans
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ardolino, L. C., Dear, R., Armstrong, A. J., Gillessen, S., & Joshua, A. M. (2023). Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6. Eur Urol, 84(4), e94–e95. https://doi.org/10.1016/j.eururo.2023.04.043
Ardolino, Luke C., Rachel Dear, Andrew J. Armstrong, Silke Gillessen, and Anthony M. Joshua. “Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6.” Eur Urol 84, no. 4 (October 2023): e94–95. https://doi.org/10.1016/j.eururo.2023.04.043.
Ardolino LC, Dear R, Armstrong AJ, Gillessen S, Joshua AM. Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6. Eur Urol. 2023 Oct;84(4):e94–5.
Ardolino, Luke C., et al. “Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6.” Eur Urol, vol. 84, no. 4, Oct. 2023, pp. e94–95. Pubmed, doi:10.1016/j.eururo.2023.04.043.
Ardolino LC, Dear R, Armstrong AJ, Gillessen S, Joshua AM. Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6. Eur Urol. 2023 Oct;84(4):e94–e95.
Published In
Eur Urol
DOI
EISSN
1873-7560
Publication Date
October 2023
Volume
84
Issue
4
Start / End Page
e94 / e95
Location
Switzerland
Related Subject Headings
- Urology & Nephrology
- Treatment Outcome
- Radiopharmaceuticals
- Radioisotopes
- Prostatic Neoplasms, Castration-Resistant
- Prostate-Specific Antigen
- Male
- Lutetium
- Humans
- 3202 Clinical sciences